Quality documentation, traceability, storage guidance and transparent supplier standards are also important
Phase 3 trials are ongoing, and without completed large-scale safety and efficacy data, the compound cannot be considered ready for routine clinical use
Trustworthy team and smooth pharmacy coordination
These include: Neurological symptoms : tingling or numbness in hands and feet (paraesthesia), difficulty walking, balance problems, memory difficulties, or mood changes Haematological signs : ongoing fatigue, weakness, pale skin, or shortness of breath suggesting anaemia hasn't resolved Glossitis : a sore, red tongue that hasn't improved Cognitive issues : continued difficulty concentrating or memory problems These symptoms, particularly progressive neurological deficits or severe anaemia with cardiorespiratory compromise, may require urgent medical attention